Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
Understand your cells’ individuality
Using label-free single cell tracking, this webinar showcases how you can monitor and quantify unique cell behavior.
2021 WSCS – A remarkable event
One click to bring you back to the 2021 World Stem Cell Summit and Regenerative Medicine Essentials Course (WSCS). Watch our inspiring and educational talk about how HoloMonitor®, as an innovative technology, can facilitate stem cell-based regenerative medicine research.
Year-end Report 2020/21
The strategic shift to focus on digital sales & marketing has been successful, reflected in the sales increase during the latter part of the fiscal year.
Growing Number of Bio-engineering Companies Purchase HoloMonitor
The regenerative medicine company Pandorum Technology recently purchased a complete HoloMonitor system.
Sahlgrenska Acquires Second HoloMonitor System
After an initial purchase by Sahlgrenska University Hospital, Sahlgrenska Center for Cancer Research acquires a second HoloMonitor system.
HoloMonitor How-to Tutorials
Learn how to handle the HoloMonitor Live Cell Imaging & Analysis System.
Succeed in tracking your cells
We at PHI are always happy to hear from you, our customers, and receive feedback and suggestions on improving your HoloMonitor® experience. Therefore, we are excited to say that we have focused on realizing many of your suggestions with the latest software update, resulting in a new and advanced Single Cell Tracking analysis.
BioSpherix Partnership Yields HoloMonitor Customer in Regenerative Medicine
Recently, the EU-funded Centre for Innovative Medicine in Vilnius purchased its first HoloMonitor analyzer for use in the center’s incubator system from BioSpherix.
Harvard Researchers Purchase HoloMonitor
Partners HealthCare International in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.
Interim Report 3 (2020-11-01 – 2021-01-31)
The second wave of the pandemic restricted sales during the 3rd quarter. However, the situation has improved significantly since late January.